Guidelines for Authors
www.karger.com/crd_guidelines
 Submission
Main Sections
Conditions
Conflict of Interest in Cardiovascular Publications
Ethics
Arrangement
Color Illustrations
References
Digital Object Identifier (DOI)
Author's ChoiceTM, NIH-Funded Research, Self-Archiving
Page Charges
Proofs
Reprints
Submission
'Cardiology' publishes original reports in research and observations pertaining to cardiovascular physiology, epidemiology, pharmacology, disease and therapy.
Only original papers written in English are considered. The articles should be readily comprehensible to a reader who is fluent in English. Therefore, all manuscripts originating from non-English-speaking authors must be edited prior to submission to assure that standard English grammar and usage are observed. This may require help from a colleague or other editorial assistant. It must be evident from the covering letter that this has been done. Submissions that are not edited in this way will not be considered for publication until such editing has been achieved.
Manuscripts should be submitted online
If you have any problems with submission, please contact:
S. Karger AG
Editorial Office 'Cardiology'
P.O. Box
CH-4009 Basel (Switzerland)
Tel. +41 61 306 1356
Fax +41 61 306 1434
crd@karger.ch
All manuscripts must be accompanied by a covering letter signed by all authors. Assurance should be given that the manuscript is not under simultaneous consideration by any other publication. The preferred word processing package is Word for Windows®. Presentation of manuscripts should conform with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (see N Engl J Med 1997;336:309–315).
Main Sections
- Original Research
- Original Research – Clinical Trial Design
Submissions will be accepted reporting the study design protocols of planned clinical trials that have been appropriately registered with regulatory authorities. These submissions will be limited to 4500 words and 35 references.
- Review
- Letter to the Editor
- Novel Insights from Clinical Experience
We invite contributions to this section that provide novel insight into a clinical problem. We recognise the value of case reports and thus submissions can be based on a single case or a number of similar cases. While a case report can describe an entirely novel clinical condition, we recognise that it is unlikely that most case reports will provide such information. In the more common setting of a description of a well-recognized condition, the most important aspect of the presentation, on which editorial judgments will be based, is the description of the new perspective(s) on the phenotype, pathophysiology, clinical presentation, evaluation strategy and/or management that can be drawn from the case findings. This category replaces the previous case report section.
Highlighted boxes containing one or two bullet points on 'Established facts' and 'Novel insights' are required and should be placed on the first page of the report. These should be selected so as to reinforce the novelty of the clinical observation.
Example
Established Facts
· Already known fact 1 ...
· Already known fact 2 ...
· ... |
Novel Insights
· New information 1 ...
· New information 2 ...
· ... |
The manuscript should be presented with an abstract (up to 200 words), brief introduction, case or case series description and results, followed by a discussion. Case reports should be no more than 2,500 words (including statements in the highlighted box) and should contain no more than 20 references.
- Short Communications
These manuscripts should not contain more than 2,000 words, including key words, essential references (not more than 15) and not more than 3 tables or figures. Such communications should represent complete, original studies and should be arranged in the same way as full length manuscripts.
Conditions
All manuscripts are subject to editorial review. Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication. Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of ‘Cardiology’ and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author’s responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
Conflict of Interest in Cardiovascular Publications
Declaration of potential conflict of interest should be part of each publication or presentation and be designated as one or more of four categories:
- No relationship
- Relationship with a For Profit Organization
- Research relationship with a For Profit or Not For Profit Organization, which should be named
- Employee of a For Profit or Not For Profit Organization
Ethics
Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute’s committee on human research. Further, they should also state that animal experiments conform to institutional standards.
Arrangement
Title page: The first page of each paper should indicate the title, the authors’ names, the institute where the work was conducted, and a short title for use as running head.
NB: Authors wishing to preserve the phonetic meaning of diacritics (PubMed reduces diacritics to their root characters) must spell their names accordingly when submitting manuscripts (e.g. Müller should be Mueller).
Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.
Key words: For indexing purposes, a list of 3–10 key words in English is essential.
For Submissions to Main Sections 1, 2 and 3:
(Original Research, Original Research – Clinical Trial Design, Review Papers,
and Short Communications)
Abstract: The abstract is an essential and most read part of the paper. It should be printed on a separate page, up to 200 words, factual, free of abbreviations (except as specifically defined within the abstract text at first use) and should be structured as follows:
- Objectives: Should describe the purpose of the study and the problem addressed; should include at least one sentence providing the rationale or justification for the study.
- Methods: should explain how the study was performed (samples and/or population, procedures, analytical methods)
- Results: Should describe the main findings with specific data and their statistical significance, if possible
- Conclusions: Should contain a succinct interpretation of the inferences to be drawn from results
Footnotes: Avoid footnotes. When essential, they are numbered consecutively and typed at the foot of the appropriate page.
Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate sheets. Tables require a heading and figures a legend, also prepared on a separate sheet. For the reproduction of illustrations, only good drawings and original photographs can be accepted; negatives or photocopies cannot be used. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations on one block for reproduction (max. size 180 x 223 mm) or provide crop marks. On the back of each illustration, indicate its number, the author’s name, and ‘top’ with a soft pencil. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1200 dpi. Please submit figure and table files in Word or PowerPoint and do not use MAC.
Color Illustrations
Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.
Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 760.00 per page.
References
In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as ‘unpublished data’ and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. (Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1997;336:309–315 www.icmje.org)
|
Examples
(a) Papers published in periodicals: Sun J, Koto H, Chung KF: Interaction of ozone and allergen challenges on bronchial responsiveness and inflammation in sensitised guinea pigs. Int Arch Allergy Immunol 1997;112:191–195.
(b) Papers published only with DOI numbers: Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.
(c) Monographs: Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger, 1996.
(d) Edited books: Parren PWHI, Burton DR: Antibodies against HIV-1 from phage display libraries: Mapping of an immune response and progress towards antiviral immunotherapy; in Capra JD (ed): Antibody Engineering. Chem Immunol. Basel, Karger, 1997, vol 65, pp 18–56.
|
Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists.
Digital Object Identifier (DOI)
S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org
Author's ChoiceTM
Karger's Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.Karger.com. The option is available for a one-time fee of CHF 2,750.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
NIH-Funded Research
The U.S. National Institutes of Health (NIH) mandates under the NIH Public Access Policy that final, peer-reviewed manuscripts appear in its digital database within 12 months of the official publication date. As a service to authors, Karger submits the final version of your article on your behalf to PubMed Central. For those selecting our premium Author's ChoiceTM service, we will send your article immediately upon publishing, accelerating the accessibility of your work without the usual embargo. More details on NIH's Public Access Policy is available here.
Self-Archiving
Karger permits authors to archive their pre-prints (i.e. pre-refereeing) or post-prints (i.e. final draft post-refereeing) on their personal or institution's servers, provided the following conditions are met: Articles may not be used for commercial purposes, must be linked to the publisher's version, and must acknowledge the publisher's copyright. Authors selecting Karger's Author's ChoiceTM feature, however, are also permitted to archive the final, published version of their article, which includes copyediting and design improvements as well as citation links.
Page Charges
There are no page charges for papers of 6 or fewer printed pages (including tables, illustrations and references). Each additional complete or partial page is charged to the author at CHF 310.00. The allotted size of a paper is equal to approx. 18 manuscript pages (including tables, illustrations and references).
Proofs
Unless indicated otherwise, proofs are sent to the first-named author and should be returned with the least possible delay. Alterations made in proofs, other than the correction of printer's errors, are charged to the author. No page proofs are supplied.
Reprints
Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.
|
|
|
| Search in this journal
|
|
|
|
For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|
Online Manuscript Submission
Guidelines
